Traditional Chinese medicine effective in treating mild Covid-19 cases, overseas study finds
Clinical trial conducted in Pakistan using Jinhua Qinggan granules, recommended for use in mainland China’s treatment of the disease, found a shorter recovery time.But researchers acknowledge that patients with severe underlying medical conditions were not included in study
An overseas clinical trial suggests that Jinhua Qinggan granules, a traditional Chinese medicine, are effective in treating mild cases of Covid-19, according to a study published earlier this week.
The paper posted on medRxiv, an online publisher of preliminary medical research findings, said a trial in August involving 300 volunteers at a Pakistani hospital showed it was effective in treating mild presentations of the disease.
The study’s participants, all adult Pakistanis with mild symptoms, were randomly assigned to receive either 5g of Jinhua Qinggan or placebo granules three times daily for 10 days. The participants were divided into two groups of 150. In total 256 patients completed the study, 129 taking Jinhua Qinggan and 127 the placebo.
Treatment using Jinhua Qinggan showed greater clinical efficacy at 82.67 per cent after 10 days, compared with the placebo group at 10.74 per cent, the researchers found.
Jinhua Qinggan, sometimes known as JHQG, comprises 12 ingredients including honeysuckle, Baikal skullcap root and sweet wormwood herb.
The median time to recover from Covid-19-related symptoms including cough, sputum, sore throat, dyspnea, headache, nasal obstruction, fatigue, and myalgia was “shorter in the JHQG group” compared with the placebo group, the researchers said.
The study was carried out by a multinational team hailing from the University of Karachi and the Indus Hospital in Karachi; the Chinese University of Hong Kong (Shenzhen); Baptist University’s School of Chinese Medicine of Hong Kong; and the Beijing Hospital of Traditional Chinese Medicine at Capital Medical University.
But the team acknowledged that study did not include patients afflicted with severe underlying medical conditions, a group that faces a higher risk of Covid-19 disease progression.
The research forms part of Beijing’s effort to prove to the international community how effective TCM can be in treating Covid-19. TCM has been widely used in mainland China to treat Covid-19, often in combination with Western medicine.
Since early 2020, Jinhua Qinggan has been one of three TCMs recommended for use in mainland China’s national standard therapy for Covid-19. Lianhua Qingwen and Xuebijing are the other two.
In January, Beijing sent a delegation to meet with World Health Organization chief Tedros Adhanom Ghebreyesus in Geneva to present a report about TCM use in treating Covid-19.
A top TCM expert last week also suggested mass distribution of the remedy as a treatment for people in Shanghai to combat the Omicron variant.
Nearly 80 per cent of them are in stable condition after TCM treatment and are finally discharged from hospitals following recovery
Zhang Boli, Tianjin University
In an interview with state-run broadcaster CGTN on May 10, Zhang Boli, a National People’s Congress deputy and head of Tianjin University of Traditional Chinese Medicine, said: “We have conducted traditional Chinese medicine treatment on a large scale … for patients such as close contacts, secondary contacts and our medical staff.”
Zhang, who has been heavily involved in Covid-19 containment efforts in China, believes that TCM intervention can help the elderly against the coronavirus and fully recover soon after. “Nearly 80 per cent of them are in stable condition after TCM treatment and are finally discharged from hospitals following recovery,” he said.
The WHO has strongly recommended Paxlovid by Pfizer to treat Covid-19. While Beijing has approved the orally administered drug for domestic use, it is hoping to see breakthroughs in developing its own oral drug for the disease.
On Wednesday, the first clinical study of China’s antiviral oral drug against Omicron – VV116 – was published in the journal Emerging Microbes and Infections.
The researchers said VV116 could effectively treat patients infected with the Omicron variant who have mild symptoms in the early stages. However, the drug would need to be administered within the first five days of infection.
Advertisement
VV116 is an oral anti-Sars-CoV-2 nucleoside candidate jointly developed by the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the Wuhan Institute of Virology. The drug has been approved for treating Covid-19 in Uzbekistan and is being studied in several phase 3 clinical trials involving patients with the disease.
The latest research was co-authored by Chinese epidemiologist Zhang Wenhong, who leads an expert panel on Covid-19 control and treatment in Shanghai.
Conducted in March, the study involved hospitalised Covid-19 patients. Most had mild symptoms, and 89 per cent had been vaccinated with one or more doses. In the VV116 group, participants received 300mg of VV116 orally every 12 hours for five days.
The results showed that the 60 patients who received VV116 within five days of their first positive test had a shorter viral shedding time than the 76 members of the control group. Those in the VV116 group spent an average of 8.56 days to test negative for Covid-19, in contrast with 11.13 days for the control group. No serious adverse reactions were reported in either group.
Original article by admin, if reproduced, please cite the source as: https://www.tcmha.com/tcmnews/traditional-chinese-medicine-effective-in-treating-mild-covid-19-cases-overseas-study-finds.html
相关推荐
-
China composes TCM therapy for patients with Omicron by studying their syndromes
China will study traditional Chinese medicine (TCM) therapy to treat patients with the Omicron strain, experts with the National Administration of Traditional Chinese Medicine said on Thursday. Practitioner said TCM could play a bigger role in COVID-19 treatment if patients with the Omicron strain showed mild symptoms or none, as studies showed, as TCM has proven effective in treating COVID-19 patients through reducing their symptoms and adjusting their immune systems. The application of TCM on Omicron-infected patients will be studied, and a treatment plan using TCM to target the Omicron…
-
Traditional Chinese Medicine Market expected to grow at a CAGR of 5.1% to reach US$ 49.6 Bn by the end of 2033
The Global revenue from the Traditional Chinese Medicine Market was around US$ 28.7 Billion in 2022, with the global market expected to grow at a CAGR of 5.1% to reach a valuation of around US$ 49.6 Billion by the end of 2033.
-
Traditional Chinese medicine maker expands amid rising overseas demand during pandemic
A Traditional Chinese medicine (TCM) maker has been accelerating its overseas registration process and expansion plans in response to booming global demand amid the ongoing coronavirus pandemic. Despite lingering difficulties in getting approval in countries such as the US and Australia, the number of overseas approvals issued for TCMs such as Lianhua Qingwen has quadrupled since the pandemic, industry insiders said, a clear indication of TCM gaining wider acceptance overseas. Chinese herbal medicine maker Yiling Pharmaceutical’s patented Lianhua Qingwen capsules have been recommended for the treatment of COVID-19 by some…
-
Why does even the US Air Force trust traditional Chinese medicine?
According to Nouvelles d’Europe, in 2018, the World Health Organization included TCM into its globally influential medical program for the first time. This shows that TCM is really an effective medical treatment that can fill in the blanks of Western medicine.
-
Demand soars for Chinese medicine to treat COVID-19 despite Australian ban
It’s the Chinese medicine often compared to paracetamol. Lianhua Qingwen has long been used in mainland China to treat common colds and flu-like symptoms. The traditional Chinese medicine is also given to children, albeit in smaller doses. Since the start of the pandemic, Chinese authorities and scientists have been saying it is even effective at easing symptoms of Covid-19. It’s prompted some members of Australia’s Chinese community to stock-up on the medication available in China over-the-counter and with a prescription. “Lianhua Qingwen is very effective for symptoms such as the…
-
Coronavirus: team of mainland traditional Chinese medicine specialists to advise Hong Kong on Covid treatments, infection control in elderly care homes
A team of traditional Chinese medicine experts arrived in Hong Kong from the mainland on Tuesday to advise the government on how to strengthen infection control in care homes for the elderly and better treat Covid-19 patients. Chief Executive Carrie Lam Cheng Yuet-ngor and local health officials received the team of seven specialists – the fourth batch of medical experts dispatched from the mainland since the city’s fifth wave of coronavirus infections began – at the Shenzhen Bay border point on Tuesday morning. Among the officials there were health minister…
-
(Chengdu Universiade) Embracing allure of TCM at FISU Games Village
From pulse diagnosis to rehabilitation services, traditional Chinese medicine (TCM) specialists are taking every measure to ensure athletes are in tip-top shape at the FISU Games Village, which is housing those participating in the ongoing 31st FISU World University Games in Chengdu, the capital city of southwest China’s Sichuan Province.
-
From flu vaccines to TCM and breast cancer: Experts advise how to take charge of your health in 2023
In the latest series of One FM Good Morning podcasts, medical experts from Parkway Shenton and Parkway East Hospital shed light on some of the most discussed health topics in Singapore
-
China to improve traditional Chinese medicine workforce
By 2025, all urban community health centers and rural township health clinics ought to have their own TCM division and personnel, so that residents can enjoy convenient access to TCM services, noted the document.
-
Interview: Behind Olympic golds, traditional Chinese medicine plays a role
As Gu Ailing won a historical gold in the women’s Freeski Big Air at the Beijing 2022 Winter Olympic Games, a doctor of the Chinese team revealed the role that Traditional Chinese Medicine (TCM) plays in treating China’s Olympians. Zhu Jiangwei, a physician at the Sichuan Province Orthopedic Hospital, worked for China’s national freeski big air and snowboard slopestyle team between October 2021 and January this year. Along with the team, Zhu traveled to Austria, Switzerland, the United States and other countries, providing medical care to members of the team,…
